Fig. 1

Performance of ELN₂₀₁₇ model in Mononuclear cells. Overall Survival probability over time by ELN₂₀₁₇ risk group in MNCs from the validation cohort (n = 166). C-statistics are for the ELN₂₀₁₇ model fit to the validation cohort for all patients (age 18.5–88.8, a), patients younger than 55 years old (N = 86, b), and patients 55 years and older (N = 80, c). The total number of patients who were at risk of death (alive and uncensored) are shown for each year of follow-up